The researchers credit wider availability of molecular testing and better understanding of the diseases for the emerging targeted therapies in development. As ongoing studies continue to investigate ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...

New York, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial ...

Short Hills, New Jersey and Adelaide, South Australia--(Newsfile Corp. - April 14, 2023) - Humanigen, Inc. (Nasdaq: HGEN), Humanigen Australia Pty Ltd, (Humanigen) and the South Australian Health and ...

DEAR DR. ROACH: My husband recently passed away one week after his 80th birthday. According to his death certificate, he died of lung cancer (not a surprise) and chronic myelomonocytic leukemia (CMML) ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage oncology company dedicated to the discovery and development of novel biotherapeutics by ...

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update. ImmuneOnco Biopharmaceuticals has announced the successful dosing of the first patient in its Phase III trial of ...

Background: A 75-year-old female presented with a 1 month history of nonbloody diarrhea, associated with abdominal cramping and urgency. Her medical history was notable for chronic myelomonocytic ...

Symptoms of chronic myelomonocytic leukemia (CMML) can include tiredness, bruising and bleeding easily, frequent infections, sweating, and bone pain. Symptoms can depend on the type of CMML. Chronic ...

Azacitidine is standard, first-line therapy in higher-risk myelodysplastic syndromes (MDS). Whether azacitidine-based combinations with lenalidomide or vorinostat produce superior overall response ...